Barclays raised the firm’s price target on Argenx (ARGX) to EUR 670 from EUR 650 and keeps an Overweight rating on the shares.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX:
- Argenx price target raised to $706 from $675 at Evercore ISI
- Argenx price target raised to $675 from $646 at Oppenheimer
- Argenx may have first targeted myositis treatment, says H.C. Wainwright
- Argenx SE Boosts Myositis Treatment Development
- Argenx to continue development of efgartigimod subcutaneous